Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Share-based Compensation (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Share-based Compensation for 7 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 92.62% to $4.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.7 million, a 83.41% decrease, with the full-year FY2025 number at $16.7 million, down 83.41% from a year prior.
  • Share-based Compensation was $4.5 million for Q4 2025 at Select Medical Holdings, up from $4.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $61.3 million in Q4 2024 to a low of $3.9 million in Q1 2025.
  • A 5-year average of $11.5 million and a median of $9.4 million in 2022 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: soared 418.45% in 2024, then crashed 92.62% in 2025.
  • Select Medical Holdings' Share-based Compensation stood at $8.9 million in 2021, then grew by 9.63% to $9.8 million in 2022, then rose by 20.6% to $11.8 million in 2023, then skyrocketed by 418.45% to $61.3 million in 2024, then plummeted by 92.62% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Share-based Compensation are $4.5 million (Q4 2025), $4.3 million (Q3 2025), and $4.0 million (Q2 2025).